| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Clínica Las Condes S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CL$15,997.00 |
| 52 Week High | CL$30,000.00 |
| 52 Week Low | CL$10,998.00 |
| Beta | -0.016 |
| 1 Month Change | -15.36% |
| 3 Month Change | -8.57% |
| 1 Year Change | 46.63% |
| 3 Year Change | -50.01% |
| 5 Year Change | -61.36% |
| Change since IPO | 324.85% |
Recent News & Updates
Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture
Apr 30
Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price
Mar 28Recent updates
Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture
Apr 30Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price
Mar 28Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture
Jan 12Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?
Oct 24Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up
Sep 27Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital
Jun 21Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt
May 19Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price
Aug 25There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital
Apr 20Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?
Mar 10There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital
Oct 07A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)
Aug 28Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?
May 31Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital
Apr 16A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns
Mar 12Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt
Feb 05Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?
Jan 01Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.
Nov 27
Shareholder Returns
| LAS CONDES | CL Healthcare | CL Market | |
|---|---|---|---|
| 7D | -3.6% | 2.7% | 1.4% |
| 1Y | 46.6% | 2.8% | 15.8% |
Return vs Industry: LAS CONDES exceeded the CL Healthcare industry which returned 2.8% over the past year.
Return vs Market: LAS CONDES exceeded the CL Market which returned 15.8% over the past year.
Price Volatility
| LAS CONDES volatility | |
|---|---|
| LAS CONDES Average Weekly Movement | 4.7% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 3.0% |
| 10% most volatile stocks in CL Market | 4.8% |
| 10% least volatile stocks in CL Market | 1.3% |
Stable Share Price: LAS CONDES has not had significant price volatility in the past 3 months.
Volatility Over Time: LAS CONDES's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of CL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 3,077 | Pablo Ortiz D. | www.clinicalascondes.cl |
Clínica Las Condes S.A. operates clinics in Chile. The company provides services in the areas of anesthesiology, adult and infant bronchopulmonary, cardiology, adult and child surgery, plastic and reconstructive surgery, dermatology, gastroenterology, obstetrics-gynecology, maxillofacial, physical medicine and rehabilitation, internal medicine, neurosurgery, adult and child neurology, nutrition, odontology, ophthalmology, otorhinolaryngology, pediatrics, child and adolescent psychiatry, adult psychiatry, traumatology and orthopedics, and urology. Clínica Las Condes S.A. was founded in 1978 and is based in Las Condes, Chile.
Clínica Las Condes S.A. Fundamentals Summary
| LAS CONDES fundamental statistics | |
|---|---|
| Market cap | CL$133.99b |
| Earnings (TTM) | -CL$3.40b |
| Revenue (TTM) | CL$202.26b |
0.7x
P/S Ratio-39.4x
P/E RatioIs LAS CONDES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LAS CONDES income statement (TTM) | |
|---|---|
| Revenue | CL$202.26b |
| Cost of Revenue | CL$143.12b |
| Gross Profit | CL$59.15b |
| Other Expenses | CL$62.55b |
| Earnings | -CL$3.40b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -406.05 |
| Gross Margin | 29.24% |
| Net Profit Margin | -1.68% |
| Debt/Equity Ratio | 71.7% |
How did LAS CONDES perform over the long term?
See historical performance and comparison